Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults

Vaccine

Volumn 25, Issue 33, 2007, Pages 6287-6291

  Kim, Sung Han ^a   Choi, Su Jin ^a   Park, Wan Beom ^a   Kim, Hong Bin ^a   Kim, Nam Joong ^a   Oh, Myoung don ^a   Choe, Kang Won ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Immunity; Smallpox; Vaccination

Indexed keywords

CJ 50300; LANCY VAXINA; PLACEBO; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ADULT; ARTICLE; CELL KINETICS; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; LYMPHADENOPATHY; MALE; MYALGIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; SMALLPOX; SMALLPOX VIRUS; VACCINIA;

ADULT; FEMALE; HUMANS; IMMUNITY, CELLULAR; KINETICS; MALE; SMALLPOX; SMALLPOX VACCINE; TIME FACTORS; VACCINIA VIRUS; VIRUS SHEDDING;

EID: 34447629719     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.05.044     Document Type: Article

References (17)

1. Tenorio A.R., Peeples M.E., Patri M., Rezai K., and Trenholme G.M. Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees. Clin Diagn Lab Immunol 11 4 (2004) 758-761
2. Greenberg R.N., Kennedy J.S., Clanton D.J., Plummer E.A., Hague L., Cruz J., et al. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Lancet 365 9457 (2005) 398-409
3. Poccia F., Gioia C., Montesano C., Martini F., Horejsh D., Castilletti C., et al. Flow cytometry and T-cell response monitoring after smallpox vaccination. Emerg Infect Dis 9 11 (2003) 1468-1470
4. CJ Corporation. Investigator's brochure for CJ-50300. Seoul, South Korea; March 2006.
5. Centers for Disease Control Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR 50 RR-10 (2001) 1-25
6. Kim S.H., Yeo S.G., Jang H.C., Park W.B., Lee C.S., Lee K.D., et al. Clinical responses to smallpox vaccine in vaccinia-naïve and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. J Infect Dis 192 6 (2005) 1066-1070
7. Newman F.K., Frey S.E., Blevins T.P., Mandava M., Bonifacio Jr. A., Yan L., et al. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine. J Clin Microbiol 41 7 (2003) 3154-3157
8. Kim S.H., Bang J.W., Park K.W., Park W.B., Kim H.B., Kim N.J., et al. Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus. J Infect Dis 194 3 (2006) 377-384
9. Kim S.H., Yeo S.G., Cho J.H., Kim H.B., Kim N.J., Oh M.D., et al. Cell-mediated immune responses to smallpox vaccination. Clin Vaccine Immunol 13 10 (2006) 1172-1174
10. Talbot T.R., Ziel E., Doersam J.K., LaFleur B., Tollefson S., and Edwards K.M. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization. Clin Infect Dis 38 4 (2003) 536-541
11. Kennedy J.S., Frey S.E., Yan L., Rothman A.L., Cruz J., Newman F.K., et al. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. J Infect Dis 190 7 (2004) 1286-1294
12. Treanor J., Wu H., Liang H., and Topham D.J. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults. Vaccine 24 47-48 (2006) 6913-6923
13. Mortimer P.P. Can postexposure vaccination against smallpox succeed?. Clin Infect Dis 36 5 (2003) 622-629
14. Nishiura H, Eichner M. Interpreting the epidemiology of postexposure vaccination against smallpox. Int J Hyg Environ Health 2007, doi:10.1016/j.ijheh.2007.01.029.
15. Breman J.G., and Henderson D.A. Diagnosis and management of smallpox. N Engl J Med 346 17 (2002) 1300-1308
16. Vollmar J., Arndtz N., Eckl K.M., Thomsen T., Petzold B., Mateo L., et al. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine 24 12 (2006) 2065-2070
17. Kenner J., Cameron F., Empig C., Jobes D.V., and Gurwith M. LC16m8: an attenuated smallpox vaccine. Vaccine 24 47-48 (2006) 7009-7022